Literature DB >> 25912151

Development and assessment of a shortened Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55).

Shane W Goodwin1,2, Anastasia I Lambrinos1, Mark A Ferro3,4,5, Mark Sabaz6, Kathy N Speechley1,2,7.   

Abstract

OBJECTIVE: To develop and validate a shortened version of the Quality of Life in Childhood Epilepsy Questionnaire (QOLCE). A secondary aim was to compare baseline risk factors predicting health-related quality of life (HRQoL) in children newly diagnosed with epilepsy, as identified using the original and shortened version.
METHODS: Data came from the Health-Related Quality of Life in Children with Epilepsy Study (HERQULES, N = 373), a multicenter prospective cohort study. Principal component analysis reduced the number of items from the original QOLCE, and factor analysis was used to assess the factor structure of the shortened version. Convergent and divergent validity was assessed by correlating the Child Health Questionnaire (CHQ) with the shortened QOLCE. Multiple regression identified risk factors at diagnosis for HRQoL at 24 months.
RESULTS: A four-factor, higher-order, 55-item solution was obtained. A total of 21 items were removed. The final model represents functioning in four dimensions of HRQoL: Cognitive, Emotional, Social, and Physical. The shortened QOLCE demonstrated acceptable fit: Bentler's Comparative Fit Index = 0.944; Tucker-Lewis Index = 0.942; root mean square approximation = 0.058 (90% CI: 0.056-0.061); weighted root mean square residuals (WRMR) = 1.582, and excellent internal consistency (α = 0.96, subscales α > 0.80). Factor loadings were good (first-order: λ = 0.66-0.93; higher-order λ = 0.66-0.85; p < 0.001 for all). The shortened QOLCE scores correlated strongly with similar subscales of the Child Health Questionnaire (ρ = 0.38-0.70) while correlating weakly with dissimilar subscales (ρ = 0.30-0.31). While controlling for HRQoL at diagnosis, predictors for better HRQoL at 24 months were the following: no cognitive problems reported (p = 0.001), better family functioning (p = 0.014), fewer family demands (p = 0.008), with an interaction between baseline HRQoL and cognitive problems (p = 0.011). SIGNIFICANCE: Results offer initial evidence regarding reliability and validity of the proposed 55-item shortened version of the QOLCE (QOLCE-55). The QOLCE-55 produced results on risk factors consistent with those found using the original measure. Given the fewer items, QOLCE-55 may be a viable option reducing respondent burden when assessing HRQoL in children with epilepsy. Wiley Periodicals, Inc.
© 2015 International League Against Epilepsy.

Entities:  

Keywords:  Children; Confirmatory factor analysis; Epilepsy; Health-related quality of life; Measurement; Psychometrics; Quality of Life in Childhood Epilepsy Questionnaire (QOLCE)

Mesh:

Year:  2015        PMID: 25912151     DOI: 10.1111/epi.13000

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

Review 1.  Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies.

Authors:  Elizabeth E Palmer; Katherine Howell; Ingrid E Scheffer
Journal:  Neurotherapeutics       Date:  2021-10-27       Impact factor: 6.088

2.  Curative Effect of Prebiotics/Probiotics-Assisted Ketogenic Diet on Children with Refractory Epilepsy.

Authors:  Lingying Su; Sai Li; Bo Sun
Journal:  Emerg Med Int       Date:  2022-05-28       Impact factor: 1.621

3.  Randomized Controlled Trial of Melatonin for Sleep Disturbance in Dravet Syndrome: The DREAMS Study.

Authors:  Kenneth A Myers; Margot J Davey; Michael Ching; Colin Ellis; Bronwyn E Grinton; Annie Roten; Paul A Lightfoot; Ingrid E Scheffer
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

4.  Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community.

Authors:  A Suraev; N Lintzeris; J Stuart; R C Kevin; R Blackburn; E Richards; J C Arnold; C Ireland; L Todd; D J Allsop; I S McGregor
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

5.  The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study.

Authors:  Darren Reithmeier; Richard Tang-Wai; Blair Seifert; Andrew W Lyon; Jane Alcorn; Bryan Acton; Scott Corley; Erin Prosser-Loose; Darrell D Mousseau; Hyun J Lim; Jose Tellez-Zenteno; Linda Huh; Edward Leung; Lionel Carmant; Richard J Huntsman
Journal:  BMC Pediatr       Date:  2018-07-07       Impact factor: 2.125

6.  A live-online mindfulness-based intervention for children living with epilepsy and their families: protocol for a randomized controlled trial of Making Mindfulness Matter©.

Authors:  Klajdi Puka; Karen Bax; Andrea Andrade; Margo Devries-Rizzo; Hema Gangam; Simon Levin; Maryam N Nouri; Asuri N Prasad; Mary Secco; Guangyong Zou; Kathy N Speechley
Journal:  Trials       Date:  2020-11-11       Impact factor: 2.279

7.  The Effect of Family Empowerment Model on Quality of Life in Children with Epilepsy in South of Iran, 2018: A Randomized Controlled Clinical Trial.

Authors:  Hamid Nemati; Zahra Mahdavi Khanouki; Mohammad Ghasempour; Ahmad Ali Amirifar; Fatemeh Alaei Karahroudi; Maryam Gholami
Journal:  Iran J Child Neurol       Date:  2021

8.  The Chinese version of the Quality of Life in Childhood Epilepsy Questionnaire-16-C (QOLCE-16-C): translation, validity, and reliability.

Authors:  Ping Tang; Qunfeng Lu; Yinghui Wu; Lin Wang; Wenjuan Tang; Yan Jiang; Liling Yang; Jianlin Ji; Xiaomin Sun; Jingmin Sun; Jie Yang
Journal:  Health Qual Life Outcomes       Date:  2022-03-28       Impact factor: 3.186

9.  Single-item measure for assessing quality of life in children with drug-resistant epilepsy.

Authors:  Lauryn Conway; Elysa Widjaja; Mary Lou Smith
Journal:  Epilepsia Open       Date:  2017-12-18

10.  Epilepsy-specific patient-reported outcome measures of children's health-related quality of life: A systematic review of measurement properties.

Authors:  Holly Crudgington; Morwenna Rogers; Hannah Morris; Paul Gringras; Deb K Pal; Christopher Morris
Journal:  Epilepsia       Date:  2020-01-17       Impact factor: 5.864

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.